Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2026 04:39 ET | Source: Research and Markets

Genomic Collaboration and Licensing Deals Report 2018-2026 | Analyze 720+ Genomic Partnerships | Access Contracts and Source Documents

Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2018-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
July 21, 2026 12:31 ET | Source: Research and Markets

Gene Therapy Collaboration and Licensing Deals Report 2016-2026: Gain Visibility into Partner Behaviour and Recurring Deal Structures

Dublin, July 21, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
July 21, 2026 12:27 ET | Source: Research and Markets

Stem Cell Collaboration and Licensing Deals Report 2010-2026: A Clear Insight into How Deal Terms Vary by Therapy Type, Development Stage, and Partner Profile

Dublin, July 21, 2026 (GLOBE NEWSWIRE) -- The "Stem Cell Collaboration and Licensing Deals 2010-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
July 21, 2026 07:02 ET | Source: Axiom Biosciences

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences, a clinical-stage biotechnology company whose lead regenerative therapy produced positive early results in newborns with severe brain...
July 20, 2026 04:31 ET | Source: Research and Markets

Cancer Monoclonal Antibody Collaboration and Licensing Deals, 2016-2026 | Presents Detailed Analysis of Upfronts, Milestones, and Royalty Structures Across Relevant Deals

Dublin, July 20, 2026 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a...
July 17, 2026 09:06 ET | Source: Research and Markets

Preclinical Stage Partnering Deals in Pharmaceuticals and Biotechnology 2020-2026: Analyze Over 1,750 Partnering Agreements

Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" has been added to ResearchAndMarkets.com's...
July 17, 2026 06:48 ET | Source: Research and Markets

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes

Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" has been added to ResearchAndMarkets.com's...
July 17, 2026 06:04 ET | Source: Research and Markets

Regenerative Medicine Collaboration and Licensing Deals 2019-2026 | Benchmark 1,500+ Regenerative Medicine Deals | Compare Upfronts, Milestones, and Royalties

Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Collaboration and Licensing Deals 2019-2026" has been added to ResearchAndMarkets.com's offering.This report provides a...
July 16, 2026 16:21 ET | Source: Cellution Biologics

Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio

Cellution Biologics signs definitive agreement to acquire SimpliDerm®, expanding its allograft portfolio and entering the U.S. breast reconstruction market
July 15, 2026 05:25 ET | Source: Research and Markets

Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec

Dublin, July 15, 2026 (GLOBE NEWSWIRE) -- The "Cell-Based Assay Services for Preclinical Use Only Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's...